These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection? Lobato MN; Jereb JA; Castro KG Pediatrics; 2009 Mar; 123(3):902-3. PubMed ID: 19255018 [No Abstract] [Full Text] [Related]
3. TB drug prices slashed for poor countries. Hagmann M Bull World Health Organ; 2001; 79(9):904-5. PubMed ID: 11584747 [No Abstract] [Full Text] [Related]
4. Antituberculosis-drug resistance. Geerligs WA; van Altena R; van der Werf TS N Engl J Med; 1998 Oct; 339(15):1079-80. PubMed ID: 9766995 [No Abstract] [Full Text] [Related]
5. Public health. Responding to market failures in tuberculosis control. Gupta R; Kim JY; Espinal MA; Caudron JM; Pecoul B; Farmer PE; Raviglione MC Science; 2001 Aug; 293(5532):1049-51. PubMed ID: 11463877 [No Abstract] [Full Text] [Related]
6. Cost-effective control of drug-resistant TB: listening to other voices. Portero JL; Rubio M PLoS Med; 2006 Dec; 3(12):e542. PubMed ID: 17194207 [No Abstract] [Full Text] [Related]
7. Response to drug resistant tuberculosis is insufficient and too slow. Cui W BMJ; 2011 Mar; 342():d1969. PubMed ID: 21444638 [No Abstract] [Full Text] [Related]
9. [Reasons for drug-resistant tuberculosis emergence]. Tu DH Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006 [No Abstract] [Full Text] [Related]
10. Editorial: the treatment of multi-drug resistant tuberculosis--a return to the pre-antibiotic era? Ollé-Goig JE Trop Med Int Health; 2006 Nov; 11(11):1625-8. PubMed ID: 17054741 [No Abstract] [Full Text] [Related]